US Bancorp’s Applied Molecular Transport Inc. Common Stock AMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-39
Closed -$12 4169
2023
Q1
$12 Hold
39
﹤0.01% 4068
2022
Q4
$16 Hold
39
﹤0.01% 4121
2022
Q3
$0 Hold
39
﹤0.01% 4266
2022
Q2
$0 Hold
39
﹤0.01% 4285
2022
Q1
$0 Sell
39
-2,110
-98% -$17.5K ﹤0.01% 4252
2021
Q4
$30K Buy
2,149
+1,687
+365% +$33.3K ﹤0.01% 2907
2021
Q3
$12K Buy
462
+423
+1,085% +$13.4K ﹤0.01% 3381
2021
Q2
$2K Buy
+39
New +$1.84K ﹤0.01% 3870

Other funds holding AMTI

US Bancorp's AMTI Position: Q2 2023 in Review

US Bancorp sold out of Applied Molecular Transport Inc. Common Stock (AMTI) in Q2 2023, closing a stake of 39 shares — an estimated $12 sold.

US Bancorp first reported a position in AMTI in Q2 2021 and held it in 8 quarters. The position peaked at $30K in Q4 2021. 28 funds tracked by Wall St. Rank hold AMTI as of Q2 2023.

  • US Bancorp reported no remaining Applied Molecular Transport Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • US Bancorp sold 39 Applied Molecular Transport Inc. Common Stock shares in Q2 2023, an estimated $12.
  • US Bancorp first reported a position in Applied Molecular Transport Inc. Common Stock in Q2 2021 and held it in 8 quarters.
  • US Bancorp's Applied Molecular Transport Inc. Common Stock position peaked at $30K in Q4 2021.
  • 28 funds tracked by Wall St. Rank held Applied Molecular Transport Inc. Common Stock as of Q2 2023.

Based on US Bancorp's 13F filing for Q2 2023, filed 10 Aug 2023.